Source comparison
Men 35-45 Sermorelin Protocol: Dosing Comparison
200–250mcg nightly Men with baseline IGF-1 >180 ng/mL, mild recovery deficits 15–25% from baseline 8–12 weeks to measurable body composition change Sleep quality improvement, minor body recomposition Effective for men with moderate baseline GH secretion who ne
This comparison does not assign a generated winner or score.
- 200–250mcg nightly
- Men with baseline IGF-1 >180 ng/mL, mild recovery deficits
- 15–25% from baseline
- 8–12 weeks to measurable body composition change
- Sleep quality improvement, minor body recomposition
- Effective for men with moderate baseline GH secretion who need recovery support without aggressive intervention
- 300–400mcg nightly
- Men with baseline IGF-1 120–180 ng/mL, moderate training volume
- 30–45% from baseline
- 6–10 weeks to measurable body composition change
- Primary body recomposition protocol, enhanced recovery
- The most common therapeutic dose range. Balances efficacy and side effect profile for most men 35-45
- 500mcg nightly
- Men with baseline IGF-1 <120 ng/mL, high training volume or severe recovery deficits
- 50–70% from baseline
- 4–8 weeks to measurable body composition change
- Aggressive recomposition, clinical hyposomatotropism
- Maximum effective dose before diminishing returns. Requires strict IGF-1 monitoring to avoid supra-physiological elevation